U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit ​and revenue, weighed down by softer demand for implants ‌and devices used in complex procedures ranging from spinal to orthopedic surgeries.